Teva Migraine Drug Wins FDA Approval | Fortune Teva Pharmaceutical Industries Ltd. won U.S. regulatory approval to sell a new treatment for migraines, a key part of the company’s turnaround strategy. The stock surged in after-hours trading. HIER WEITERLESEN: FORTUNE.COM
Gerade in Zeiten wie diesen, wichtiger denn je: ILI News am 31.03.2024 – ISRAEL IM KRIEG | ILI – I Like Israel e.V. 01.04.2024
Hamas Denies Terrorist Presence at Gaza’s Al-Shifa Hospital in English – but Celebrates It in Arabic | Algemeiner.com 04.04.2024
Gallant: Captured Hamas operatives reveal group’s internal collapse – „Hundreds of terrorists have been apprehended, and their testimonies shed light on the internal strife within Hamas“ | I24news 01.04.2024
Hinterlasse eine Antwort
Sie müssen... (sein)angemeldet sein um einen Kommentar zu schreiben.